Revance Therapeutics Inc. (RVNC)
NASDAQ: RVNC
· Real-Time Price · USD
3.65
0.00 (0.00%)
At close: Feb 05, 2025, 3:59 PM
Revance Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for RVNC stock have an median target of 3.1, with a low estimate of 3 and a high estimate of 6.6. The median target predicts a decrease of -15.07% from the current stock price of 3.65.
| Target | Low | Average | Median | High |
|---|---|---|---|---|
| Price | 3 | 4.23 | 3.1 | 6.6 |
| Change | -17.81% | 15.89% | -15.07% | 80.82% |
Latest Analyst Insight Report
HC Wainwright & Co. maintains a Neutral rating on ... Unlock content with Pro Subscription
Updated Nov 08, 2024
| Rating | Sep 24 | Oct 24 | Nov 24 | Dec 24 | Jan 25 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 2 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 2 | 2 | 1 |
Financial Forecast this Year
Revenue This Year
250.14M
from 234.04M
Increased by 6.9%
Revenue Next Year
320.07M
from 250.14M
Increased by 28.0%
EPS This Year
-1.14
from -3.83
Increased by 70.2%
EPS Next Year
-0.7
from -1.14
Increased by 38.6%